Publikationen 2023

Strik H., Efferth T., Kaina B. (2023) Artesunate in glioblastoma therapy: Case reports and review of clinical studies, Phytomedicine, 155274

Kaina B. (2023) Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications, Journal of Clinical Medicine, 12, 7442, doi.org/10.3390/jcm12237442

Stanfill S. B., Hecht S.S., Joerger A.C., González P.J., Maia L.B., Rivas M.G., Moura J.J.G., Gupta A.K., Le Brun N.E., Crack J.C., Hainaut P., Sparacino-Watkins C., Tyx R.E., Pillai S.D., Zaatari G.S., Henley S.J., Blount B.C., Watson C.H., Kaina B., Mehrotra R. (2023) From cultivation to cancer: formation of N-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implications, Critical Reviews in Toxicology, doi.org/10.1080/104084444.2023.2264327

Köberle B., Usanova S., Piée-Staffa A., Heinicke U., Clauss P., Brozovic A, Kaina B. (2023) Strong apoptotic response of testis tumor cells following cisplatin treatment, International Urology and Nefrology, doi.org/10.1007/s11255-023-03825-5

P. Kovac M.; Tadic V., Kralj J., E. Duran G., Stefanelli A., S. Polancec D., Dabelic S., Bacic N., Tomicic Maja T., Heffeter P., I. Sikic B., Brozovic A. (2023) Carboplatin-induced upregulation of pan ß-tubulin and class III ß-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer, Cellular and Molecular Life Sciences, 80:294

Reuss D.E., Downing S.M., Camacho C.V., Wang Y.-D., Piro R.M., Herold-Mende C., Wang Z.-Q., Hofmann T.G., Sahm F., von Deimling A., Mc Kinnon P.J., Frapaprt P.-O. (2023) Simultaneous Nbs1 and p53 inactivation in neural progenitors triggers High-Grade Gliomas (HGG), Neuropathology and Applied Neurobiology, e12915. doi: 10.1111/nan.12915. Online ahead of print

Müller A., Weyerhäuser P., Berte N., Jonin F., Lyubarskyy B., Sprang B., Kantelhardt S.R., Salinas G., Opitz L., Schulz-Schaeffer W., Giese A., Kim E.L. (2023) Concurrent activation of both survival-promoting and death-inducing signaling by chloroquine in glioblastoma stem cells: implication for potential risks and benefits of using chloroquine as radiosensitizer, Cells, 12 (9), 1290

Rotheneder M., Stakyte K., van de Logt E., Bartho J.D., Lammens K., Fan Y., Alt A., Kessler B., Jung C., Roos W.P., Steigenberger B., Hopfner K-P. (2023) Cryo-EM structure of the Mre11-Rad50-Nbs1 complex reveals the molecular mechanism of scaffolding functions, Molecular Cell, 83, 1-19 Elsevier Inc

Sigismondo G., Arseni L., Palacio-Escat N., Hofmann T.G., Seiffert M., Krijgsveld J. (2023) Multi-layered chromatin proteomics identifies cell vulnerabilities in DNA repair, Nucleic Acids Research, 51 (2), 687-711

Rashan L.J., Özenver N., Boulos J.C., Dawood M., Roos W.P., Franke K., Papasotiriou J., Wessjohann L.A., Fiebig H-H., Efferth T. (2023) Molecular modes of action of an aqueous Nerium oleander extract in cancer cells in vitro and in vivo, Molecules, 28, 1871

Fahrer J., Christmann M. (2023) DNA alkylation damage by nitrosamines and relevant DNA repair pathways, International Journal of Molecular Sciences, 24 (5), 4684

Buchbeiträge:

Pons M., Beyer M. (2023) Colony formation assay to test the impact of HDACi on leukemic cells, Oliver H. Krämer (ed.), HDAC/HAT Function Assessment and Inhibitor Development: Methods and Protocols, Methods in Molecular Biology, vol. 2589, chapter 02

Pons M., Conradi R., Brenner W., Krämer O.H. (2023) Human platelet lysate as valid cell growth additive to assess protein acetylation, Oliver H. Krämer (ed.), HDAC/HAT Function Assessment and Inhibitor Development: Methods and Protocols, Methods in Molecular Biology, vol. 2589, chapter 06

Krämer O.H., Diehl T., Roos W.P. (2023) Assessing the effect of histone deacetylase inhibitors on DNA double-strand break repair by nonhomologous end joining, Oliver H. Krämer (ed.), HDAC/HAT Function Assessment and Inhibitor Development: Methods and Protocols, Methods in Molecular Biology, vol. 2589, chapter 19

M. Mustafa Al-H., Ashry R., Krämer O.H. (2023), Monitoring changes in intracellular reactive oxygen species levels in response to histone deacetylase inhibitors, Oliver H. Krämer (ed.), HDAC/HAT Function Assessment and Inhibitor Development: Methods and Protocols, Methods in Molecular Biology, vol. 2589, chapter 22

Gül D., Olf S., Hagemann J., Stauber R.H., Krämer O.H. (2023), Cloning strategy for HDAC1/HDAC2 hybrid protein expression in mammalian cells, Oliver H. Krämer (ed.), HDAC/HAT Function Assessment and Inhibitor Development: Methods and Protocols, Methods in Molecular Biology, vol. 2589, chapter 26